pre-IPO PHARMA

COMPANY OVERVIEW

Arecor Limited is a biopharmaceutical company transforming patient care by bringing innovative medicines to market. Through the enhancement of existing medicines using our Arestat™ technology, we are developing a broad portfolio of therapies as part of our proprietary pipeline and through partnerships with leading pharmaceutical and biotech companies. Our treatments for people living with chronic disease are designed to simplify patient care and improve medication adherence.


LOCATION

  • Little Chesterford, , UK

  • THERAPEUTIC AREAS

  • Metabolic DIsorders

  • WEBSITE

    https://arecor.com


    CAREER WEBSITE

    https://arecor.com/careers/


    SOCIAL MEDIA


    INVESTORS

    unilever-ventures


    PRESS RELEASES


    Jul 20, 2023

    Arecor: Business Update


    Aug 1, 2022

    Xeris’ Commercialization Partner for Ogluo, Tetris Pharma Ltd, to Be Acquired by Arecor Therapeutics


    May 18, 2022

    ARECOR TO HOST KOL WEBINAR ON THE NEED FOR CONCENTRATED AND RAPID ACTING INSULIN TREATMENTS IN DIABETES CARE


    Apr 28, 2022

    ARECOR PRESENTS FULL DATA FROM POSITIVE PHASE I CLINICAL TRIAL OF AT278 ULTRA-CONCENTRATED ULTRA-RAPID ACTING INSULIN FOR DIABETES AT ATTD MEETING


    Apr 12, 2022

    Arecor Announces Oral Presentation at Attd 2022 of Phase i Clinical Trial of At278 Ultra-Concentrated Ultra-Rapid Acting Insulin for Diabetes


    For More Press Releases


    Google Analytics Alternative